drugset / Trial / NCT05243953

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache

NCT05243953

Completed 21 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindBasic science

Summary

The aim is to investigate whether opening of ATP-sensitive potassium (KATP) channels induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

Timeline

Start
2022-03-21
Primary completion
2022-07-07
Completion
2022-07-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levcromakalim Small molecule 0.05 mg Intravenous

Indications

No indication recorded.